restructuring

cardiovascular disease
Biotech

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Japanese biotech Heartseed said it was "difficult to reasonably foresee" that Novo would scrap the 2021 deal, despite the pharma's restructuring.
Zoey Becker Sep 30, 2025 1:55pm
workers

Fierce Biotech Layoff Tracker 2025: Heidelberg, IO & more

Sep 30, 2025 11:00am
Novo Nordisk
Favicon Fierce Pharma

Novo Nordisk tells employees they must return to office Jan. 1

Sep 11, 2025 2:13pm
Doustdar
Favicon Fierce Pharma

Novo charts major restructuring, layoffs under new CEO

Sep 10, 2025 8:41am
reducing people on team

Evotec's reorg claims 600 jobs, 200 more than originally planned

Aug 14, 2025 2:44pm
A series of dice with a bag on them illustrating cost cuts

Prothena lays off 63% in fallout from phase 3 amyloidosis fail

Jun 20, 2025 2:23am